The world’s landscape is quickly evolving due to both innovation and government policy. Ensuring that these policies match political and commercial goals is possible through the expertise of CBPartners’ team.
Showing 1 of 1 posts
August 13, 2019 | Blogs
Since the Chinese government brought a deluge of reforms to their pharmaceutical sector in 2018, it is no surprise 2019 is shaping up to be another game-changing year. CBPartners' Asia-Pacific Center of Excellence delivered insights about the evolving NRDL in China, as well as strategic considerations for pharmaceutical manufacturers.